First Fiduciary Investment Counsel’s Amgen AMGN Stock Holding History

First Fiduciary Investment Counsel’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.12M	Buy	25,171 +1,603	+7%	+$549K	1.72%	27
2026 Q1	$8.29M	Buy	23,568 +5,713	+32%	+$2.04M	1.67%	28
2025 Q4	$5.84M	Sell	17,855 -15	-0.1%	-$4.76K	1.13%	31
2025 Q3	$5.04M	Buy	17,870 +625	+4%	+$181K	0.98%	34
2025 Q2	$4.82M	Buy	17,245 +1,069	+7%	+$303K	0.95%	35
2025 Q1	$5.04M	Buy	+16,176	New	+$4.78M	1.08%	35
2020 Q1	–	Sell	-1,100	Closed	-$265K	–	60
2019 Q4	$265K	Buy	+1,100	New	+$242K	0.05%	59

Other funds holding AMGN

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

First Fiduciary Investment Counsel's AMGN Position: Q2 2026 in Review

First Fiduciary Investment Counsel increased its Amgen (AMGN) stake by 6.8% in Q2 2026, buying an estimated $549K and bringing the position to 25,171 shares worth $9.12M. The position accounts for 1.72% of the portfolio, ranked #27.

First Fiduciary Investment Counsel first reported a position in AMGN in Q4 2019 and has held it in 7 quarters since. 1,625 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

First Fiduciary Investment Counsel held 25,171 shares of Amgen worth $9.12M as of Q2 2026.
First Fiduciary Investment Counsel bought 1,603 Amgen shares in Q2 2026, an estimated $549K.
Amgen made up 1.72% of First Fiduciary Investment Counsel's portfolio in Q2 2026, its #27 holding.
First Fiduciary Investment Counsel first reported a position in Amgen in Q4 2019 and has held it in 7 quarters since.
1,625 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on First Fiduciary Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.